Brief: Median Technologies: Promising Results On Study To Identify Severity Of Disease In Patients With NASH

Median Technologies SA

24/11/2020 16:56

Nov 24 (Reuters) - Median Technologies SA  ALMDT.PA :
    * IBIOPSY®: PROMISING RESULTS ON A PRELIMINARY STUDY TO
IDENTIFY
THE SEVERITY OF THE DISEASE IN PATIENTS WITH NON-ALCOHOLIC
STEATOHEPATITIS (NASH)
    * RESULTS SHOW THAT IBIOPSY® NON-INVASIVE FIBROSIS BIOMARKER
FOR
NASH COULD ALLOW FOR DISCRIMINATION BETWEEN EARLY AND ADVANCED
FIBROSIS BASED ON STANDARD IMAGING MODALITIES
    * RESULTS NEED TO BE CONFIRMED ON INDEPENDENT PATIENT
COHORTS

Source text for Eikon:  ID:nBw9JBzlla 
Further company coverage:  ALMDT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))